Skip to main content
LNA Santé logo

LNA Santé — Investor Relations & Filings

Ticker · LNA ISIN · FR0004170017 LEI · 969500FULTKJYIRIAT87 PA Human health and social work activities
Open in API
Filings indexed 557 across all filing types
Latest filing 2019-09-18 Earnings Release
Country FR France
Listing PA LNA

About LNA Santé

https://www.lna-sante.com/

LNA Santé is a healthcare operator focused on providing care for vulnerable individuals. The company manages and operates a diverse network of facilities, including medicalized nursing homes that offer long-term care and specialized support for neurodegenerative diseases like Alzheimer's and Parkinson's. Its portfolio also includes Medical Care and Rehabilitation (SMR) establishments for post-acute and follow-up care, surgical clinics, and mental health clinics. In addition to its residential and outpatient facilities, LNA Santé provides hospital-at-home (HAD) services, delivering complex medical care directly to patients' residences. The organization's integrated approach serves individuals facing temporary or permanent loss of autonomy, disabilities, or the need for specialized medical treatment and rehabilitation.

Recent filings

Filing Released Lang Actions
LNA SANTE: Résultats Semestriels 2019
Earnings Release Classification · 99% confidence The document is titled "RESULTATS DU 1er SEMESTRE 2019" (First Half 2019 Results) and contains detailed financial tables comparing H1 2019 results to H1 2018, including revenue, EBITDA, and net income. It explicitly mentions that the Board of Directors 'a arrêté les comptes semestriels 2019' (approved the 2019 semi-annual accounts). The content is a comprehensive financial report covering a period shorter than a year (six months). This aligns perfectly with the definition of an Interim / Quarterly Report (IR). It is not an Earnings Release (ER) because it is a detailed report with full annexes, not just highlights. It is also not a 10-K (Annual Report). H1 2019
2019-09-18 French
LNA Santé : Répartition de capital et des droits de vote attachés aux actions au 31/08/2019
Share Issue/Capital Change Classification · 95% confidence The document is titled "Déclaration au titre de l'article 223-16 du règlement général de l'Autorité des Marchés Financiers" and provides a breakdown of the capital structure and voting rights ("Répartition de capital et des droits de vote") as of a specific date (31/08/2019). This type of mandatory disclosure, detailing the total number of shares and voting rights, is a specific regulatory filing related to share capital structure, often required by financial market authorities (AMF in France). It is not a full annual report (10-K), an earnings release (ER), or a general management/board change announcement (MANG). Since it specifically details the composition of capital and voting rights, it most closely aligns with a disclosure related to share capital changes or major shareholdings, but given the specific nature of reporting total voting rights under French regulation (Article 223-16 AMF), it is a specific regulatory disclosure. Among the provided codes, it is a specific regulatory filing that doesn't fit perfectly into the defined categories like DIV, SHA, or MRQ, which usually relate to transactions or thresholds. However, since it is a formal, mandatory disclosure of the capital base, it is best classified as a specific regulatory filing. Given the options, and noting it is a formal disclosure about the capital base, it is closest to a general regulatory filing or a share-related disclosure. Since it is a formal declaration of the capital structure itself, and not a transaction (POS/SHA) or a threshold crossing (MRQ), the most appropriate general category for a specific, non-standard regulatory disclosure is RNS, or potentially SHA if interpreted broadly as a capital structure report. Given the context of mandatory reporting of capital structure details, and lacking a specific 'Capital Structure Disclosure' code, RNS (Regulatory Filings) serves as the best fit for this specific regulatory declaration not covered by the other specific codes.
2019-09-06 French
LNA Santé : répartition de capital et des droits de vote attachés aux actions au 31/07/2019
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled "Déclaration au titre de l'article 223-16 du règlement général de l'Autorité des Marchés Financiers" and provides the "Répartition de capital et des droits de vote attachés aux actions au 31/07/2019" (Capital and voting rights breakdown as of 07/31/2019). This content specifically details the total number of shares, gross voting rights, and exercisable voting rights, which is a mandatory regulatory disclosure in France (AMF regulation). This type of disclosure, focusing on capital structure and voting rights, is most closely aligned with general regulatory announcements or specific capital/share information. Since it is a formal regulatory declaration about the capital structure and voting rights, it fits best under the general 'Regulatory Filings' (RNS) category as a specific regulatory disclosure that isn't explicitly covered by other codes like DIV, SHA, or DIRS, although it relates to share capital. Given the context of mandatory regulatory reporting to the AMF regarding capital structure, RNS is the most appropriate general regulatory fallback.
2019-08-08 French
LNA SANTE: Chiffre d'Affaires du 1er semestre 2019
Earnings Release Classification · 99% confidence The document is a press release dated July 18, 2019, detailing the company's financial performance for the Second Quarter (T2 2019) and the First Half (S1 2019). It highlights key metrics like Operating Revenue (Chiffre d'affaires Exploitation), organic growth, and provides a revised outlook for the full year 2019 objectives. This content structure—a summary of recent financial results, key performance indicators, and management commentary—is characteristic of an Earnings Release (ER). It is not the full, comprehensive report (like a 10-K or IR), nor is it a transcript (CT) or a formal presentation (IP). The final line mentions that the full half-year results will be published on September 18, 2019, confirming this document is the preliminary announcement of results. H1 2019
2019-07-18 French
LNA SANTE: Nouveau contrat de liquidité
Share Issue/Capital Change Classification · 99% confidence The document is a press release dated July 9, 2019, announcing the implementation of a liquidity contract ('CONTRAT DE LIQUIDITE') with ODDO BHF SCA, effective retroactively from January 2, 2019. It details the allocated resources (€700,000 and 7,300 shares) and the conditions under which the contract can be suspended or terminated. This announcement concerns a specific financial arrangement related to market making/liquidity provision, which is a form of capital/financing activity or market operation. It does not fit perfectly into the standard reporting categories (10-K, IR, ER). It is most closely related to 'Capital/Financing Update' (CAP) as it deals with the structure and management of the company's stock liquidity, or potentially 'Regulatory Filings' (RNS) as a general market announcement. Given the specific nature of establishing a liquidity contract, 'CAP' (Capital/Financing Update) is the most appropriate fit among the defined categories, as it relates to managing capital market presence and structure, even if it's not a direct fundraising event. Since it is a specific announcement about a financial mechanism, it is more specific than the general fallback RNS.
2019-07-09 French
LNA SANTE : Bilan semestriel du contrat de liquidité au 30/06/2019
Capital/Financing Update Classification · 99% confidence The document is a 'Communiqué' (Press Release/Announcement) dated July 5, 2019, detailing the semi-annual balance sheet ('bilan semestriel') of a liquidity contract (market making agreement) between LNA Santé and ODDO BHF, covering the period ending June 30, 2019. This document reports on specific financial/trading activities (liquidity provision, share transactions, and cash balances) related to market operations, rather than being a comprehensive financial report (like 10-K or IR) or a standard earnings release (ER). It most closely aligns with an announcement concerning capital/financing activities or a specific regulatory disclosure related to market operations. Given the focus on share transactions under a liquidity contract, it relates to capital management or trading activity. Since there is no specific category for 'Liquidity Contract Report', the closest fit among the provided options that deals with share transactions and capital structure management is 'Capital/Financing Update' (CAP) or potentially 'Regulatory Filings' (RNS) if it's a mandatory disclosure. However, because it details the execution of transactions (buy/sell volumes) under a formal agreement, 'CAP' is a reasonable fit, although 'RNS' (General Regulatory Filings) is often used for specific, non-standard disclosures. Given the nature of reporting on share transactions under a formal agreement, I will classify it as a specific regulatory disclosure that doesn't fit elsewhere, leaning towards RNS, but acknowledging its relation to share activity. Upon review, this type of report detailing the status of a liquidity contract (which involves managing share supply/demand) is often categorized under general regulatory announcements if not explicitly covered. I will select RNS as the most appropriate fallback for a specific, non-standard regulatory disclosure.
2019-07-08 French

Browse filings by year

19 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.